Longitudinal Trajectories of Estimated Glomerular Filtration Rate in a European Population of Living Kidney Donors.

IF 2.7 3区 医学 Q1 SURGERY Transplant International Pub Date : 2024-08-26 DOI:10.3389/ti.2024.13356
Manuela Almeida,Pedro Reis Pereira,José Silvano,Catarina Ribeiro,Sofia Pedroso,Sandra Tafulo,La Salete Martins,Miguel Silva Ramos,Jorge Malheiro
{"title":"Longitudinal Trajectories of Estimated Glomerular Filtration Rate in a European Population of Living Kidney Donors.","authors":"Manuela Almeida,Pedro Reis Pereira,José Silvano,Catarina Ribeiro,Sofia Pedroso,Sandra Tafulo,La Salete Martins,Miguel Silva Ramos,Jorge Malheiro","doi":"10.3389/ti.2024.13356","DOIUrl":null,"url":null,"abstract":"A living donor (LD) kidney transplant is the best treatment for kidney failure, but LDs safety is paramount. We sought to evaluate our LDs cohort's longitudinal changes in estimated glomerular filtration rate (eGFR). We retrospectively studied 320 LDs submitted to nephrectomy between 1998 and 2020. The primary outcome was the eGFR change until 15 years (y) post-donation. Subgroup analysis considered distinct donor characteristics and kidney function reduction rate (%KFRR) post-donation [-(eGFR6 months(M)-eGFRpre-donation)/eGFRpre-donation*100]. Donors had a mean age of 47.3 ± 10.5 years, 71% female. Overall, LDs presented an average eGFR change 6 M onward of +0.35 mL/min/1.73 m2/year. The period with the highest increase was 6 M-2 Y, with a mean eGFR change of +0.85L/min/1.73 m2/year. Recovery plateaued at 10 years. Normal weight donors presented significantly better recovery of eGFR +0.59 mL/min/1.73 m2/year, compared to obese donors -0.18L/min/1.73 m2/year (p = 0.020). Noteworthy, these results only hold for the first 5 years. The subgroup with a lower KFRR (<26.2%) had a significantly higher decrease in eGFR overall of -0.21 mL/min/1.73 m2/year compared to the groups with higher KFRR (p < 0.001). These differences only hold for 6 M-2 Y. Moreover, an eGFR<50 mL/min/1.73 m2 was a rare event, with ≤5% prevalence in the 2-15 Y span, correlating with eGFR pre-donation. Our data show that eGFR recovery is significant and may last until 10 years post-donation. However, some subgroups presented more ominous kidney function trajectories.","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"9 1","pages":"13356"},"PeriodicalIF":2.7000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/ti.2024.13356","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

A living donor (LD) kidney transplant is the best treatment for kidney failure, but LDs safety is paramount. We sought to evaluate our LDs cohort's longitudinal changes in estimated glomerular filtration rate (eGFR). We retrospectively studied 320 LDs submitted to nephrectomy between 1998 and 2020. The primary outcome was the eGFR change until 15 years (y) post-donation. Subgroup analysis considered distinct donor characteristics and kidney function reduction rate (%KFRR) post-donation [-(eGFR6 months(M)-eGFRpre-donation)/eGFRpre-donation*100]. Donors had a mean age of 47.3 ± 10.5 years, 71% female. Overall, LDs presented an average eGFR change 6 M onward of +0.35 mL/min/1.73 m2/year. The period with the highest increase was 6 M-2 Y, with a mean eGFR change of +0.85L/min/1.73 m2/year. Recovery plateaued at 10 years. Normal weight donors presented significantly better recovery of eGFR +0.59 mL/min/1.73 m2/year, compared to obese donors -0.18L/min/1.73 m2/year (p = 0.020). Noteworthy, these results only hold for the first 5 years. The subgroup with a lower KFRR (<26.2%) had a significantly higher decrease in eGFR overall of -0.21 mL/min/1.73 m2/year compared to the groups with higher KFRR (p < 0.001). These differences only hold for 6 M-2 Y. Moreover, an eGFR<50 mL/min/1.73 m2 was a rare event, with ≤5% prevalence in the 2-15 Y span, correlating with eGFR pre-donation. Our data show that eGFR recovery is significant and may last until 10 years post-donation. However, some subgroups presented more ominous kidney function trajectories.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
欧洲活体肾脏捐献者估计肾小球滤过率的纵向轨迹。
活体肾移植是治疗肾衰竭的最佳方法,但活体肾移植的安全性至关重要。我们试图评估 LDs 队列中估计肾小球滤过率(eGFR)的纵向变化。我们对 1998 年至 2020 年间接受肾切除术的 320 例 LD 进行了回顾性研究。主要结果是捐献后 15 年(y)前的 eGFR 变化。亚组分析考虑了不同捐献者的特征和捐献后肾功能减退率(%KFRR)[-(eGFR6个月(M)-捐献前eGFR)/捐献前eGFR*100]。捐献者的平均年龄为 47.3 ± 10.5 岁,71% 为女性。总体而言,捐献者的 eGFR 在 6 M 以后的平均变化为 +0.35 mL/min/1.73 m2/年。增长最快的时期是 6 M-2 Y,平均 eGFR 变化为 +0.85升/分钟/1.73 平方米/年。10 年后恢复趋于平稳。与肥胖捐献者相比,正常体重捐献者的 eGFR 恢复明显更好,为 +0.59 mL/min/1.73 m2/年,而肥胖捐献者为 -0.18L/min/1.73 m2/年(p = 0.020)。值得注意的是,这些结果只适用于最初的 5 年。与 KFRR 较高的组别相比,KFRR 较低(<26.2%)的亚组 eGFR 整体下降幅度显著较高,为-0.21 mL/min/1.73 m2/年(p < 0.001)。此外,eGFR<50 mL/min/1.73 m2 是一种罕见情况,在 2-15 年期间的发生率≤5%,与捐献前的 eGFR 相关。我们的数据显示,eGFR 的恢复非常明显,可能会持续到捐献后 10 年。然而,一些亚组的肾功能轨迹更不乐观。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transplant International
Transplant International 医学-外科
CiteScore
4.70
自引率
6.50%
发文量
211
审稿时长
3-8 weeks
期刊介绍: The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. The journal is published in yearly volumes, each volume containing twelve issues. Papers submitted to the journal are subject to peer review.
期刊最新文献
Normothermic Machine Perfusion Reconstitutes Porcine Kidney Tissue Metabolism But Induces an Inflammatory Response, Which Is Reduced by Complement C5 Inhibition. Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation - Is It Time to Test? Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm. The impact of the EVLP on the lung microbiome and its inflammatory reaction. Adjusted Donor Age: A Clinical Score to Support Organ Acceptance Decisions in Deceased-Donor Kidney Transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1